Measuring Glycaemic Variation

被引:31
作者
Cameron, Fergus J. [1 ,2 ]
Donath, Susan M.
Baghurst, Peter A. [3 ,4 ]
机构
[1] Univ Melbourne, Murdoch Childrens Res Inst Parkville, Royal Childrens Hosp, Dept Endocrinol & Diabet, Melbourne, Vic 3052, Australia
[2] Univ Melbourne, Murdoch Childrens Res Inst Parkville, Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Melbourne, Vic 3052, Australia
[3] Womens & Childrens Hosp, Children Youth & Womens Hlth Serv, Publ Hlth Res Unit, Adelaide, SA, Australia
[4] Univ Adelaide, Fac Hlth Sci, Discipline Paediat, Adelaide, SA, Australia
关键词
Glycaemic variation; Measurement; Comparison;
D O I
10.2174/157339910790442592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The measurement of glycaemic variation (GV) is conceived to be of clinical significance in determining diabetes outcomes. The debate as to the importance of GV has been complicated by studies using various meetrics of GV in qualitatively different datasets. The purpose of this review is to discuss the properties of 8 of the more commonly used metrics (M-value, MAGE, "J"-index, CONGA, BG rate of change, ADRR, Lability/HYPO score and GRADE). Comparable metrics that can be used to measure continuous glycaemic measurements (CGM) (SDBGL, "J"-index, MAGE, CONGA, GRADE) were then compared in assessing diabetic and non-diabetic datasets. In non-diabetic conditions there was very close correlation (correlation coefficients > 0.92) between SDBGL, MAGE and CONGA, however under diabetic conditions the correlation coefficients of the GV metrics diminished significantly. The varying GV metrics have varying inherent properties depending upon the purpose for which they were designed and should not be seen as being interchangeable. Investigators therefore need to be clear about the nature of their enquiry of GV and choose an appropriate metric.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 47 条
  • [1] [Anonymous], 1995, DIABETES, V44, P968
  • [2] QUALITY-CONTROL OF INTENSIFIED INSULIN THERAPY - HBA(1) VERSUS BLOOD-GLUCOSE
    BISCHOF, F
    MEYERHOFF, C
    PFEIFFER, EF
    [J]. HORMONE AND METABOLIC RESEARCH, 1994, 26 (12) : 574 - 578
  • [3] Type 1 diabetes and glucose monitoring
    Bloomgarden, Zachary T.
    [J]. DIABETES CARE, 2007, 30 (11) : 2965 - 2971
  • [4] Glucose variability and complications
    Bolli, Geremia B.
    [J]. DIABETES CARE, 2006, 29 (07) : 1707 - 1709
  • [5] Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd, J.
    Adamson, U.
    Backlund, L. B.
    Lins, P. E.
    Moberg, E.
    Oskarsson, P.
    [J]. DIABETES & METABOLISM, 2008, 34 (06) : 612 - 616
  • [6] Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1681
  • [7] In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine
    Bruttomesso, D.
    Crazzolara, D.
    Maran, A.
    Costa, S.
    Dal Pos, M.
    Girelli, A.
    Lepore, G.
    Aragona, M.
    Iori, E.
    Valentini, U.
    Del Prato, S.
    Tiengo, A.
    Buhr, A.
    Trevisan, R.
    Baritussio, A.
    [J]. DIABETIC MEDICINE, 2008, 25 (03) : 326 - 332
  • [8] Bugler J., 2008, 1 INT C ADV TECHN TR, P55
  • [9] Postprandial hyperglycemia and diabetes complications - Is it time to treat?
    Ceriello, A
    [J]. DIABETES, 2005, 54 (01) : 1 - 7
  • [10] Prediction of severe hypoglycemia
    Cox, Daniel J.
    Gonder-Frederick, Linda
    Ritterband, Lee
    Clarke, William
    Kovatchev, Boris P.
    [J]. DIABETES CARE, 2007, 30 (06) : 1370 - 1373